TBI vs MAN

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Nov 05, 2026

TBI

34.3
AI Score
VS
MAN Wins

MAN

61.0
AI Score

Investment Advisor Scores

TBI

34score
Recommendation
AVOID NEW MONEY

MAN

61score
Recommendation
BUY

AI Analyst Insights

Detailed Metrics Comparison

Metric TBI MAN Winner
Forward P/E 11.2108 10.1215 MAN
PEG Ratio 0.8011 0.943 TBI
Revenue Growth 11.8% 4.4% TBI
Earnings Growth -63.4% 86.8% MAN
Tradestie Score 34.3/100 61.0/100 MAN
Profit Margin -3.4% 0.6% MAN
Beta 1.00 1.00 Tie
AI Recommendation AVOID NEW MONEY BUY MAN

Relative Price Performance (Last 90 Days)

TBI 1M: +39.2% · 3M: +20.7% MAN 1M: -11.4% · 3M: -21.0%

Current Technical Phase

TBI

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 73

RSI (14): 73.2 · Price: $12.35

MAN

Markdown
Sell / avoid

Price below a falling SMA50 (slope -9.9%), weak momentum, RSI 44

RSI (14): 44.2 · Price: $46.05

Fundamentals Snapshot

Metric TBI MAN
Market Cap — —
Forward P/E 14.4 9.9
Trailing P/E — 18.2
Revenue (TTM) — —
Revenue Growth 0.2% 0.0%
Gross Margin 0.2% 0.2%
Operating Margin 0.0% 0.0%
EPS -1.52 2.53
Dividend Yield — 0.03%

Frequently Asked Questions

Based on our detailed analysis, MAN is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.